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Abstract
Background: Human immunodeficiency virus (HIV) and antiretroviral therapy (ART) have both been shown to reduce bone mineral 
density, mineralisation and bone turnover. Our study group and other researchers have suggested that HIV may impair fracture 
healing, based on extrapolation from basic science. These observations prompted this study as the true effect of HIV and highly active 
antiretroviral therapy (HAART) on bone healing is very poorly understood and has not previously been investigated.
Methods: HOST Study is a multicentre case-cohort study being undertaken at two orthopaedic trauma centres in Cape Town, South 
Africa. All adult patients older than 18 years with fresh (within 2 weeks of injury), closed and open, tibia and femur fractures who 
undergo intramedullary (IM) nailing for fracture fixation will be eligible for the study. Participants will be recruited over 24 months 
and undergo a baseline questionnaire, HIV testing and assessment of their bone mineral density (BMD). They will be followed up at 
2 and 6 weeks, and at 3, 6, 9 and 12 months. All adult patients who develop delayed bone union at the 6-month follow-up will be 
considered cases. Adult patients who show evidence of radiological union at 6 months or less will be considered controls. We will 
then determine if HIV is a risk factor for the development of delayed bone union. HIV prevalence levels in the cases and controls will 
be summarised using IRR (incidence rate ratio) statistics with their 95% confidence intervals. Negative binomial regression methods 
will be used to adjust the IRR estimates for the possible effects of confounding factors and/or important covariates.
Results: Outcomes from the primary manuscript will be disseminated through publications in academic journals and presentations 
at relevant orthopaedic conferences. We will communicate trial results to all participating sites. Participating sites will communicate 
results with patients who have indicated an interest in knowing the results.
Trial registration number: ClinicalTrials.gov - NCT03131947
Site of study: Groote Schuur Hospital and Tygerberg Hospital, Cape Town, South Africa
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Introduction
Worldwide approximately 35.3 million people are HIV positive, 
with the highest prevalence seen in sub-Saharan Africa.1 The 
introduction of antiretroviral therapy (ART) in 1997 has altered the 
course and nature of patients infected with HIV by increasing the 
duration of asymptomatic infection, and consequently patients 
with HIV are attaining close-to-normal life spans. However, 
despite these longer life expectancies, there is little evidence 
to advise the surgeon and patient about the effect of long-term 
immunosuppression on the fracture repair process in orthopaedic 
surgery.2
HIV principally affects a patient’s immunological status by 
reducing the host CD4 T cell count, resulting in an increase in 
the risk of a patient developing opportunistic infections. HIV has 
also been shown to affect other chemical mediators, including 
interleukins 1 and 6 and tumour necrosis factor (TNF), which have 
been shown to play a role in the fracture repair process.3-5
HIV and ART have both been shown to reduce bone mineral 
density (BMD), bone mineralisation and bone turnover.6-9 In the 
general population, it has been postulated that a reduced BMD 
is associated with a reduced speed of fracture healing.10,11 If this 
relationship were to hold true in the context of HIV, then they 
would not only be at an increased risk of fragility fracture, but 
also of subsequent delayed fracture healing and failure of fracture 
fixation. 
A major factor known to affect fracture healing is local blood 
flow to the site of the injury. It is now well established that HIV 
infection is associated with osteonecrosis, due to interruption in 
osseous blood supply, although no mechanism for this interruption 
in blood supply has been shown.12-14 ART has also been reported to 
contribute to this pathology.12 Conditions that jeopardise arterial 
flow to the site of primary bone healing are associated with higher 
rates of delayed fracture healing and non-union.15-17
A small number of studies have investigated the role of HIV in 
the fracture-healing process. These have suggested that HIV and/
or ART are associated with delayed fracture healing and may result 
in non-union.11,18 The molecular and cellular mechanisms driving 
this process remain unclear and the true effect of HIV and ART on 
bone healing is very poorly understood.
Our study group has previously demonstrated an association 
between HIV infection and impaired fracture healing.18,19 
Furthermore, analysis of patients presenting to Queen Elizabeth 
Central Hospital, Blantyre, Malawi, for immediate fracture 
treatment and non-union surgery, indicates twice the frequency 
of HIV seropositivity in the non-union group (Figure 1) (personal 
communication – Professor WJ Harrison). Other researchers 
have suggested that HIV may impair fracture healing, based on 
extrapolation from basic science.11 
These observations prompted this study as the true effect of HIV 
on bone healing is very poorly understood and has not previously 
been thoroughly investigated.
Study objectives
Our primary objective is to establish whether HIV is a risk factor for 
the development of delayed bone union or non-union following a 
fracture.
Secondary objectives are:
• To assess other risk factors associated with delayed bone union 
or non-union in HIV-positive and -negative adults, e.g. BMD, ART
• To determine the incidence of superficial, deep and late wound 
infections in HIV-positive and -negative patients
• To quantify and draw inferences on observed differences in the 
Disability Rating Index (DRI) and general health-related quality 
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Figure 1. Numbers of patients presenting to QECH for intramedullary nailing for fresh fractures and non-unions: 2005–2007
Adults treated with IM for a fracture of 
the tibia or femur
(n=146)
Non-union (n=70)
HIV +ve (n=28) HIV +ve (n=15)HIV -ve (n=42) HIV -ve (n=61)
Fresh (n=76)Type of fracture
HIV status
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of life after fracture healing following IM nailing fracture surgery 
in HIV-positive and -negative patients.
Methods 
Study design 
HOST Study is a multicentre case cohort study of patients 
undergoing fracture surgery within the Orthopaedic and Trauma 
Department at Groote Schuur Hospital (GSH) and Tygerberg 
Hospital (TBH), Cape Town, South Africa. 
Patient selection and recruitment
Patients older than 18 years of age with fresh (within 2 weeks of 
injury), closed and open, tibia and femur fractures who undergo IM 
nailing for fracture fixation will be potentially eligible for inclusion 
in the study. Participants will undergo a baseline questionnaire, 
and established risk factors for delayed bone healing and non-
union will be recorded. The patients’ full blood count, renal 
function, vitamin D level and albumin will be assessed. All patients 
will undergo HIV testing and a measurement of the patients CD4 
count and viral load if positive. If a patient is found to have a new 
diagnosis of HIV, standard local hospital protocol will be followed, 
and the patient will be offered treatment. If the patient is already 
known to be HIV positive, their ART regimen will be recorded, 
if appropriate. Furthermore, all patients will have their BMD 
measured using a DEXA Heel Scanner, Calscan DXL.
X-rays will be performed at follow-up visits or if clinically 
required. Bone healing will be assessed using a validated X-ray 
scoring system – the Radiological Union Scoring system for the 
Tibia (RUST scoring system).20,21 An independent observer blinded 
to HIV status will assess radiological fracture union. Participants 
will be recruited over 24 months.
All adult patients treated with IM nailing of the tibia or femur 
and who develop delayed bone union at 6 months follow-up 
will be considered cases. Adult patients who show evidence of 
radiological union at 6 months or less will be considered controls.
Inclusion criteria
Patients will be eligible for this study if they:
• Are older than 18 years of age
• Present within 2 weeks of injury
• Sustained a closed or open fracture of the tibia or femur
• Undergo IM nailing for fracture fixation 
Exclusion criteria
Patients will be excluded from participation in this study 
in the case of:
• Major head injury
• Pre-surgical infection at the fracture site
• Open injury for >48 hours before the first debridement
• Severe burns
• Pathological fracture
• Evidence that the patient would be unable to adhere to study 
procedures, complete questionnaires or attend follow-up
Patients who sustain injuries to areas of the body other than the 
lower limbs, which may affect the primary outcome measure, will 
have their injuries documented but the participants will still be 
included in the analysis. For patients with more than one lower 
limb injury that meets the inclusion criteria, each injury will be 
included as an individual case and entered separately into the 
study.
Study outcome 
Primary study outcome:
• Incidence of delayed bone union in HIV-positive and -negative 
patients
Secondary study outcomes:
• Incidence of non-union in HIV-positive and -negative patients
• Other risk factors associated with delayed bone union or non-
union in HIV-positive and -negative adults, e.g. BMD, ART
• Incidence of superficial, deep and late wound infections in HIV-
positive and -negative patients
• To quantify and draw inferences on observed differences in 
the DRI and general health-related quality of life after fracture 
healing following IM nailing fracture surgery in HIV-positive and 
-negative patients
Outcome definitions
Union: 
• Radiological union on RUST score (score of 3 on at least three 
cortices in AP, lateral, medial or posterior cortex – a total of 9 or 
more) within 6 months of surgery20,21
Delayed bone union:
• Impaired bone healing at six months (RUST score < 9)22-26 
• Non-union – one or both of the following:
 ▫ Need for further surgery to achieve union22,23 
 ▫ Impaired bone healing at nine months (RUST score < 9)20,21
Superficial wound infection
• Superficial surgical site infection (SSI) 
The Center for Disease Control and Prevention definition of a 
‘superficial surgical site infection’ is a wound infection involving 
the skin and subcutaneous tissue that occurs after 30 days of 
surgery (where day 1 = the procedure date).27
• ASEPSIS (28)
ASEPSIS scores >20 within 30 days of surgery
Deep wound infection
The Center for Disease Control and Prevention definition of a 
‘deep surgical site infection’ is a wound infection involving the 
tissues deep to the skin that occurs within 30 days of injury (closed 
reduction of fracture) or 90 days (open reduction of fracture).27 
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Late wound infection
This describes any late wound breakdown (>30 days for closed 
reduction of fractures or >90 days for openly reduced fractures) 
or sinus formation, or unexplained late pain with associated 
radiological changes consistent with peri-implant sepsis. This will 
be determined on clinic follow-up for those still under review. 
Those patients who do not present for follow-up will be phoned 
and asked about the above.
EuroQol EQ-5D-5L 
The EuroQol EQ-5D is a validated measure of health-related quality 
of life, consisting of a five-dimension health status classification 
system and a separate visual analogue scale.23 An updated version 
of the EQ-5D with five response levels, the EQ-5D-5L, has recently 
been developed to enhance the responsiveness of the instrument 
to changes in patient health.24 
Disability Rating Index (DRI) 
The DRI is a self-administered, 12-item Visual Analogue Scale 
questionnaire assessing the patients’ own rating of their disability.22 
This measure was chosen as it addresses ‘gross body movements’ 
rather than specific joints or body segments. Therefore, it will 
facilitate the assessment of patients with different fractures and 
injuries of the lower limbs. This outcome measure will not be 
taken for those patients with longer term (more than 4 weeks) 
impaired capacity.
Bone mineral density
• Normal – T score of <1 standard deviations (T score <−1) below 
the peak bone mass of a healthy young adult
• Osteopaenia – T score of 1 to 2.5 standard deviations (T score 
−1 to −2.5) below the peak bone mass of a healthy young adult
• Osteoporosis – T score of >2.5 standard deviations (T score 
<−2.5) below the peak bone mass of a healthy young adult
Follow-up
The full visit-assessment schedule for the study is provided in 
Table I. Participants will be followed up in the clinic during the 
12-month period of follow-up (see study schedule Table I). At 12 
months, this may be via phone where appropriate. X-rays will be 
performed at 3, 6 and 9 months or if clinically indicated. 
If a patient is confirmed to have united on RUST score at 
3 months, they will be followed up in the clinic at 6 and 9 months 
and have a telephone consultation at 12 months. The same will 
be done for patients who are confirmed to have united at 6 and 
9 months follow-up. 
All patients who have not united by 3, 6 or 9 months will have 
a follow-up clinic visit at 12 months. If there is no evidence of 
union at 9 months on RUST score, or the patient has undergone a 
procedure or intervention to assist healing, they will be classified 
as non-union. The 12-month follow-up will be the final follow-
up time point for the study, either face-to-face or via telephonic 
communication, even though a patient may need further clinical 
follow-up for other reasons.
Statistical plan
Sample size
Our current register suggests that 400 patients are likely to 
undergo IM nailing of the tibia and femur at our centres over a 
two-year study period; 80% (320) are assumed to be eligible for 
inclusion. 
On the basis of previous research, it is estimated that 85% (272) 
of the 320 patients will have union at 6 months (control), and 15% 
(48) will have delayed bone union (cases)27,29 (Figure 2). 
Assuming that 20% of the controls will be HIV-positive,30 the 
sample size will have 82.8% power to detect a doubling of HIV 
prevalence in the cases compared to controls (from 20% to 40% at 
the 5% significance level).
Statistical methods
As all consenting patients who present during the study period for 
IM nailing of the tibia and femur will be recruited, HIV prevalence 
Figure 2. Study sample size
Adults treated with IM nailing for a 
fracture of the tibia or femur
(n=400)
Exclusion/drop out (n=80)
Enrolment
Delayed bone union (cases n=48)
HIV +ve (n=19) HIV +ve (n=54)ExposureHIV -ve (n=29) HIV -ve (n=218)
No delayed bone union (controls n=272)
Follow up 
6 months
Analysis
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levels in the cases and controls will be summarised using IRR 
statistics with their 95% confidence intervals. Negative binomial 
regression methods will be used to adjust the IRR estimates for 
the possible effects of confounding factors and/or important 
covariates.
Basic descriptive analysis of demographic data and 
patient characteristics
Means and standard deviations are used for continuous data along 
a normal distribution, e.g. age. Level of education will be collected 
as continuous data and categorised by researchers. It will be 
analysed using graphs and tables. A confidence interval of 95% will 
be used. P values of <0.05 are considered statistically significant.
Data management
Standard operating procedures for data management without 
breach of confidentiality will be followed. Study participants will 
be assigned a unique study number at the time of recruitment, 
under which all electronic data will be captured. From this 
point, all data will be stored in a password-protected electronic 
database. Consent forms and case record forms will be kept in a 
locked filing cabinet in the research office. Only members of the 
study team (chief investigator, clinical officers and research nurse) 
will have access to these. Data will be entered into the electronic 
study database and managed by a data management team. All 
data exports will be stored on password-protected computers 
and backed up. The chief investigator and study supervisors will 
have control of access to the data. Only de-identified data will be 
exported for analysis.
Conclusion
This is the largest study of its type to assess the effect of HIV 
and ART on bone healing. It has been suggested that HIV causes 
delayed bone union and is a risk factor for the development of 
non-union following a fracture. If this hypothesis is  shown to be 
true, fracture management could be tailored to optimise bone 
union during the fracture-healing phase in HIV-positive patients, 
improving outcomes and reducing the substantial social burden 
that occurs in these patients.31 If this hypothesis is shown to 
be incorrect then this study will demonstrate that HIV-positive 
patients can be treated in the same way as HIV-negative patients 
when managing orthopaedic skeletal trauma.
Table I. Summary of data collection plan on electronic database
Classification Study measurements/Study visits 
Base
line 2 weeks 6 weeks 3 months 6 months 9 months 12 months
Predictor HIV status/test X     
Predictor HIV investigations (CD4 count, viral load), if applicable X   X X X  
Risk factor Other lab investigations (FBC, renal function, albumin, Vit D) X       
Risk factor Socio-demographic characteristics & medical history X       
Risk factor Body mass index (BMI) X     
Risk factor Bone mineral density (BMD) assessment X     
Intervention Injury & treatment detail X       
Outcome Disability Rating Index (DRI) X   X X X  
Outcome EQ-5D-5L score X  X X X  
Adverse 
events ASEPSIS wound score  X X     
Adverse 
events Infection assessment SSI  X X     
Adverse 
events Infection assessment DSI  X X X    
Adverse 
events Infection assessment late infection     X X X
Adverse 
events Record complications/interventions  X X X X X X
Concomitant 
treatment
Record concomitant ART, NSAID and 
steroid use X X X X X X X
Concomitant 
treatment Record rehabilitation  X X X X X X
Main outcome Radiographic Union Score for Tibial (RUST) fractures   X X X X X
Functional union    X X X X
 Test performed once at baseline or within 6 weeks
 Recorded once only, either at baseline or within 3 months
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Ethics statement
The HOST study has received local and the University of Cape 
Town and University of Stellenbosch Faculty of Health Science 
Human Ethics Committee approval – reference number 590/2016 
and N17/05/052. 
The author/s declare that this submission is in accordance with 
the principles laid down by the Responsible Research Publication 
Position Statements as developed at the 2nd World Conference on 
Research Integrity in Singapore, 2010.
No other intervention will be performed other than the standard 
treatment according to our unit’s policies and current best 
evidence. HIV testing is offered to all patients of our study units, 
based on the recommendations of the Department of Health HIV 
counselling and Testing Policy Guidelines. 
All study team members will undergo good clinical practice 
training prior to commencement of study. Informed consent will 
be obtained from all study participants, either written or witnessed 
verbal consent, with thumbprint if the participant is illiterate. 
Since a substantial proportion of participants will be HIV positive, 
every effort will be made to safeguard patient confidentiality as 
outlined above.
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